NanoGroup S.A. cordially invites all interested parties to participate in the investor chat, which will be held on Monday, October 28, 2024 at 3:00 p.m. on the Stockwatch.pl portal.
The meeting will be attended by:
- Przemysław Mazurek, President of the Management Board,
- Piotr Mierzejewski, Vice President of the Management Board,
- Piotr Burliński, Operations Director.
Representatives of the company will present key information regarding the development of the NanOX system – a unique solution designed for the perfusion of organs collected for transplantation in extracorporeal conditions. They will also answer questions regarding research and development works, as well as plans related to the commercialization of the system.
Main chat topics:
- NanOX System – key information: presentation of the market in which we operate and the main assumptions of the project
- NanOX Device vs. NanOX Fluid: Discussing Two Independent But Complementary System Components
- Project phases: details about system development and implementation at different stages
- Comparison with existing solutions: how our technology compares to competitive products available on the market
- Partners and subcontractors: cooperation with key partners who support us in production and implementation processes
- Commercialization Principles: Discussion of Agreements and NanOX Market Introduction Strategy
The chat will also feature visuals, including photos and videos from isolated organ perfusion studies, that will illustrate key stages of our research and development work.
When: Monday, October 28, 2024
Time: 15.00
Where: Stockwatch.pl portal
We encourage you to participate and ask questions about NanoGroup’s innovative solutions. The investor chat is an excellent opportunity to learn more about our activities and plans related to the development of groundbreaking medical technologies that have the potential to revolutionize the transplant market.